Lokavant is a clinical intelligence platform that improves the time, cost, and quality of trial planning and execution through data-driven analytics applications. Lokavant's platform aggregates and integrates real-time data from disparate trial data sources, and powers advanced analytics enabled by its compendium of proprietary trial data. The suite of applications built on the platform allows study teams to proactively plan and manage their studies and surface insights, driving efficiencies in all scientific and operational use cases.
Edison Partners leads $21 million growth funding round for clinical trial intelligence disruptor Lokavant
Edison Partners, a leading growth equity...
The investments discussed in the above video do not represent a full list of Edison investments. A full list of Edison investments can be found here:https://www.edisonpartners.com/portfolio. There is no guarantee that the performance of these past investments may be replicated. Investors may not gain exposure to these specific investments. Past performance is not indicative of future results.
The video may contain one or more endorsement of Edison’s services. Edison did not compensate anyone for these endorsements, nor do they receive any form of indirect compensation. The experiences discussed may not be the experience of every portfolio company or investor.
